Informações:
Falhas:
ID
32713
Descrição
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Palavras-chave
Versões (1)
- 13/11/2018 13/11/2018 -
Titular dos direitos
GSK group of companies
Transferido a
13 de novembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Estimation of Dose Proportionality of Darapladib - 107038
PGx-Pharmacogenetic Research Consent
- StudyEvent: ODM
Similar models
PGx-Pharmacogenetic Research Consent
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
PGx-Pharmacogenetic Research Consent Question
Has Informed consent been obtained for PGx-Pharmacogenetic research?
Item
Has Informed consent been obtained for PGx-Pharmacogenetic research?
boolean
If YES, record Date informed consent obtained for PGx-Pharmacogenetic research
Item
If YES, record Date informed consent obtained for PGx-Pharmacogenetic research
date
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator (2)
CL Item
Other (3)
If OTHER, specify
Item
If OTHER, specify
text
Has a blood sample been collected for PGx-pharmacogenetic research?
Item
Has a blood sample been collected for PGx-pharmacogenetic research?
boolean
If YES, record date sample taken
Item
If YES, record date sample taken
boolean